Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
-1.68% $21.13
America/New_York / 31 okt 2023 @ 15:58
FUNDAMENTALS | |
---|---|
MarketCap: | 334.12 mill |
EPS: | -0.200 |
P/E: | -105.65 |
Earnings Date: | Mar 30, 2023 |
SharesOutstanding: | 15.81 mill |
Avg Daily Volume: | 0.213 mill |
RATING 2023-11-03 |
---|
B- |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Sell | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -105.65 | sector: PE -18.15 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -105.65 | industry: PE -25.74 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 21.67 - 21.73 ( +/- 0.12%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-30 | Forbion Growth Sponsor Feac I B.v. | Sell | 2 000 000 | Class A Ordinary Shares |
2023-10-30 | Forbion Growth Sponsor Feac I B.v. | Sell | 666 666 | Warrant (Right to Buy) |
2023-10-27 | Forbion Growth Sponsor Feac I B.v. | Buy | 1 373 496 | Class A Ordinary Shares |
2023-10-27 | Forbion Growth Sponsor Feac I B.v. | Buy | 1 000 000 | Warrant (Right to Buy) |
2023-10-27 | Forbion Growth Sponsor Feac I B.v. | Sell | 1 373 496 | Class B Ordinary Shares |
INSIDER POWER |
---|
-26.15 |
Last 5 transactions |
Buy: 2 373 496 | Sell: 4 040 162 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $21.13 (-1.68% ) |
Volume | 0.0590 mill |
Avg. Vol. | 0.213 mill |
% of Avg. Vol | 27.64 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware.